APA (7th ed.) Citation

JH, W., MJ, L., DD, Z., XW, W., & P, H. (2026). ADGRF4 and ADGRL4 as novel prognostic biomarkers and potential therapeutic implications in stomach adenocarcinoma. BMC gastroenterology, 26(1), . https://doi.org/10.1186/s12876-026-04913-3

Chicago Style (17th ed.) Citation

JH, Wang, Li MJ, Zang DD, Wang XW, and Huang P. "ADGRF4 and ADGRL4 as Novel Prognostic Biomarkers and Potential Therapeutic Implications in Stomach Adenocarcinoma." BMC Gastroenterology 26, no. 1 (2026). https://doi.org/10.1186/s12876-026-04913-3.

MLA (9th ed.) Citation

JH, Wang, et al. "ADGRF4 and ADGRL4 as Novel Prognostic Biomarkers and Potential Therapeutic Implications in Stomach Adenocarcinoma." BMC Gastroenterology, vol. 26, no. 1, 2026, https://doi.org/10.1186/s12876-026-04913-3.